FDA approves Zinbryta to treat multiple sclerosis - FDA Press Releases

The U.S. Food and Drug Administration today approved Zinbryta (daclizumab) for the treatment of adults with relapsing forms of multiple sclerosis (MS). Zinbryta is a long-acting injection that is self- administered by the patient monthly.

from Food and Drug Administration--Press Releases http://ift.tt/1NSUJ9Y
via IFTTT